It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
The objective of the study is to define the most appropriate region for intensity normalization in brain 18FDG PET semi-quantitative analysis. The best option could be based on previous absolute quantification studies, which showed that the metabolic changes related to ageing affect the quasi-totality of brain regions in healthy subjects. Consequently, brain metabolic changes related to ageing were evaluated in two populations of healthy controls who underwent conventional (n = 56) or digital (n = 78) 18FDG PET/CT. The median correlation coefficients between age and the metabolism of each 120 atlas brain region were reported for 120 distinct intensity normalizations (according to the 120 regions). SPM linear regression analyses with age were performed on most significant normalizations (FWE, p < 0.05).
Results
The cerebellum and pons were the two sole regions showing median coefficients of correlation with age less than − 0.5. With SPM, the intensity normalization by the pons provided at least 1.7- and 2.5-fold more significant cluster volumes than other normalizations for conventional and digital PET, respectively.
Conclusions
The pons is the most appropriate area for brain 18FDG PET intensity normalization for examining the metabolic changes through ageing.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Université de Lorraine, Department of Nuclear Medicine and Nancyclotep Imaging Platform, Nancy, France (GRID:grid.29172.3f) (ISNI:0000 0001 2194 6418); Université de Lorraine, IADI, INSERM U1254, Nancy, France (GRID:grid.29172.3f) (ISNI:0000 0001 2194 6418)
2 Aix-Marseille Université, CNRS, Ecole Centrale de Marseille, UMR 7249, Institut Fresnel, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817); Aix-Marseille University, CERIMED, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817)
3 Aix-Marseille Université, CNRS, Ecole Centrale de Marseille, UMR 7249, Institut Fresnel, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817); Aix-Marseille University, CERIMED, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817); Timone University Hospital, Department of Nuclear Medicine, Assistance Publique Hôpitaux de Marseille, Marseille, France (GRID:grid.411266.6) (ISNI:0000 0001 0404 1115)